scholarly article | Q13442814 |
P356 | DOI | 10.4315/0362-028X-72.4.733 |
P698 | PubMed publication ID | 19435220 |
P50 | author | Ian F. Connerton | Q42414271 |
Andrew E Scott | Q56057054 | ||
Andrew Timms | Q68081111 | ||
P2093 | author name string | Ayman El-Shibiny | |
Ian Connerton | |||
Phillippa Connerton | |||
Yasser Metawea | |||
P2860 | cites work | Bacteriophage therapy | Q24550616 |
Genomic diversity of Campylobacter coli and Campylobacter jejuni isolates recovered from free-range broiler farms and comparison with isolates of various origins | Q30476301 | ||
Genome dynamics of Campylobacter jejuni in response to bacteriophage predation | Q33295218 | ||
Characterization of Campylobacter phages including analysis of host range by selected Campylobacter Penner serotypes | Q33303064 | ||
Enumeration and diversity of campylobacters and bacteriophages isolated during the rearing cycles of free-range and organic chickens | Q33716421 | ||
Correlation of Campylobacter bacteriophage with reduced presence of hosts in broiler chicken ceca. | Q33913222 | ||
Rapid pulsed-field gel electrophoresis protocol for subtyping of Campylobacter jejuni | Q33972305 | ||
Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control | Q33986903 | ||
Pharmacokinetic principles of bacteriophage therapy. | Q35089166 | ||
Isolation and characterization of Campylobacter bacteriophages from retail poultry. | Q35209124 | ||
Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages | Q35210425 | ||
Bacteriophages as biocontrol agents in food. | Q36052554 | ||
Bacteriophage control of foodborne bacteriat | Q36128582 | ||
Overcoming the phage replication threshold: a mathematical model with implications for phage therapy | Q39686807 | ||
Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens | Q39799157 | ||
Application of host-specific bacteriophages to the surface of chicken skin leads to a reduction in recovery of Campylobacter jejuni. | Q39913513 | ||
Longitudinal study of Campylobacter jejuni bacteriophages and their hosts from broiler chickens. | Q41031583 | ||
Phase-variable surface structures are required for infection of Campylobacter jejuni by bacteriophages | Q41486107 | ||
Quantitative risk assessment of human campylobacteriosis associated with thermophilic Campylobacter species in chickens | Q43032869 | ||
Prevalence and numbers of Salmonella and Campylobacter spp. on raw, whole chickens in relation to sampling methods | Q44011221 | ||
Understanding bacteriophage therapy as a density-dependent kinetic process. | Q44672404 | ||
Models of phage growth and their applicability to phage therapy | Q47200464 | ||
Campylobacter succession in broiler chickens. | Q54438059 | ||
Free-range layer chickens as a source of Campylobacter bacteriophage. | Q54444396 | ||
Bacteriophage Therapy | Q56389875 | ||
Campylobacter spp. contamination of chicken carcasses during processing in relation to flock colonisation | Q57935802 | ||
P433 | issue | 4 | |
P921 | main subject | Campylobacter jejuni | Q265488 |
broiler | Q326301 | ||
Campylobacter | Q131488 | ||
bacteriophage | Q165028 | ||
Campylobacter coli | Q1031711 | ||
P304 | page(s) | 733-740 | |
P577 | publication date | 2009-04-01 | |
P1433 | published in | Journal of Food Protection | Q15761591 |
P1476 | title | Application of a group II Campylobacter bacteriophage to reduce strains of Campylobacter jejuni and Campylobacter coli colonizing broiler chickens | |
P478 | volume | 72 |
Q47346588 | A multiplex real-time PCR for the detection and differentiation of Campylobacter phages. |
Q38576127 | Alternative bacteriophage life cycles: the carrier state of Campylobacter jejuni |
Q89697883 | Application of Campylobacter jejuni Phages: Challenges and Perspectives |
Q35598730 | Bacteriophage F336 recognizes the capsular phosphoramidate modification of Campylobacter jejuni NCTC11168 |
Q37174605 | Bacteriophage biocontrol of foodborne pathogens |
Q41718786 | Bacteriophage therapy to combat bacterial infections in poultry |
Q42780037 | Bacteriophage-Mediated Dispersal of Campylobacter jejuni Biofilms |
Q42029552 | Bacteriophages and their role in food safety |
Q94569687 | Bacteriophages to Control Campylobacter in Commercially Farmed Broiler Chickens, in Australia |
Q40070554 | Bacteriophages: The possible solution to treat pathogenic bacteria |
Q26752523 | Biocontrol and Rapid Detection of Food-Borne Pathogens Using Bacteriophages and Endolysins |
Q92525129 | Campylobacter Phage Isolation and Characterization: What We Have Learned So Far |
Q34174080 | Campylobacter bacteriophages and bacteriophage therapy |
Q37863851 | Campylobacter control in poultry by current intervention measures ineffective: urgent need for intensified fundamental research |
Q35752715 | Campylobacter group II phage CP21 is the prototype of a new subgroup revealing a distinct modular genome organization and host specificity. |
Q35193011 | Campylobacter jejuni group III phage CP81 contains many T4-like genes without belonging to the T4-type phage group: implications for the evolution of T4 phages |
Q36114497 | Campylobacters and their bacteriophages from chicken liver: The prospect for phage biocontrol |
Q42265285 | Characterisation of Aerotolerant Forms of a Robust Chicken Colonizing Campylobacter coli. |
Q35248613 | Characterization of a ViI-like phage specific to Escherichia coli O157:H7. |
Q28537874 | Colonisation of a phage susceptible Campylobacter jejuni population in two phage positive broiler flocks |
Q41008182 | Combined Application of Essential Oil Compounds and Bacteriophage to Inhibit Growth of Staphylococcus aureus In Vitro |
Q36135129 | Control of Campylobacter spp. and Yersinia enterocolitica by virulent bacteriophages |
Q30252159 | Control of campylobacter in poultry industry from farm to poultry processing unit: A review. |
Q38626191 | Control strategies against Campylobacter at the poultry production level: biosecurity measures, feed additives and vaccination |
Q37716765 | Current and Potential Treatments for Reducing Campylobacter Colonization in Animal Hosts and Disease in Humans |
Q89861043 | Development of a Lyophilization Process for Campylobacter Bacteriophage Storage and Transport |
Q42265920 | Effect of bacteriophage application on Campylobacter jejuni loads in commercial broiler flocks |
Q33547699 | Evidence for a lineage of virulent bacteriophages that target Campylobacter |
Q41981034 | Expression and delivery of an endolysin to combat Clostridium perfringens |
Q28396111 | Global Epidemiology of Campylobacter Infection |
Q38871507 | Host adaption to the bacteriophage carrier state of Campylobacter jejuni |
Q35036500 | Impact of a single phage and a phage cocktail application in broilers on reduction of Campylobacter jejuni and development of resistance |
Q34562421 | Microplate-test for the rapid determination of bacteriophage-susceptibility of Campylobacter isolates-development and validation |
Q39325189 | Monitoring Salmonella, Campylobacter, Escherichia coli and Staphylococcus aureus in traditional free-range 'Label Rouge' broiler production: a 23-year survey programme |
Q35082668 | Pentavalent single-domain antibodies reduce Campylobacter jejuni motility and colonization in chickens |
Q64102381 | Phage Biocontrol of in Chickens Does Not Produce Collateral Effects on the Gut Microbiota |
Q38285489 | Phage approved in food, why not as a therapeutic? |
Q33559532 | Phage therapy to reduce preprocessing Salmonella infections in market-weight swine |
Q40267322 | Physiological and Molecular Characterization of Salmonella Bacteriophages Previously Used in Phage Therapy |
Q59321425 | Prevalence of Campylobacter jejuni in chicken produced by major poultry companies in Saudi Arabia |
Q34942249 | Primary isolation strain determines both phage type and receptors recognised by Campylobacter jejuni bacteriophages |
Q34633705 | Reducing Campylobacter jejuni colonization of poultry via vaccination |
Q34663447 | Reduction of Campylobacter jejuni in broiler chicken by successive application of group II and group III phages. |
Q47149787 | Scientific Opinion on Campylobacter in broiler meat production: control options and performance objectives and/or targets at different stages of the food chain |
Q39428290 | Strategies for Pathogen Biocontrol Using Lactic Acid Bacteria and Their Metabolites: A Focus on Meat Ecosystems and Industrial Environments |
Q37447180 | The Minor Flagellin of Campylobacter jejuni (FlaB) Confers Defensive Properties against Bacteriophage Infection |
Q42085233 | The complete genome sequence of bacteriophage CP21 reveals modular shuffling in Campylobacter group II phages |
Q39083103 | The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages. |
Q30988850 | The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens |
Q57986009 | ThermotolerantCampylobacterduring Broiler Rearing: Risk Factors and Intervention |
Q91925483 | Veterinary use of bacteriophage therapy in intensively-reared livestock |
Search more.